Interventions to promote adherence to endocrine therapy among breast cancer survivors: A meta‐analysis
- 4 December 2018
- journal article
- review article
- Published by Wiley in Psycho-Oncology
- Vol. 28 (2) , 255-263
Abstract
Objective: Adjuvant endocrine therapy (AET) significantly reduces risk of breast cancer recurrence in those patients whose tumor tests hormone (estrogen and/or progesterone) receptor positive. Many who are prescribed AET do not adhere adequately. Studies have sought to examine the effects of interventions to enhance patients' AET adherence, with strikingly mixed results. In order to reconcile a disparate literature, this paper aims to (1) quantitatively review the aggregate effect of interventions designed to optimize AET adherence within the current literature and (2) meta‐analyze these effects across studies' by intervention design.Methods: Duplicate searches were conducted using multiple electronic databases as well as hand searches of recent year conference abstracts. Studies were included that (1) tested an intervention to promote AET adherence; (2) reported at least one measure of medication adherence; and (3) reported (or provided upon request) data sufficient to calculate effect size. Effect sizes were calculated using random effects models.Results: Seven studies representing eight unique interventions were included. We observed an overall null effect across all interventions (k = 8;d[95% CI] = 0.28 [−0.05, 0.61]); however, sensitivity analyses showed that interventions that used bi‐directional communication showed statistically significant effects relative to control groups within each study (k = 4;d[95% CI] = 0.59 [0.23, 0.95]) while those relying only on providing information to the patient (one‐way communication) did not (k = 4;d[95% CI] = −0.03 [−0.27, 0.20]).Conclusions: Interventions that promote patient self‐report may improve AET adherence through enhancing patient engagement. Investigators and clinicians who wish to optimize medication adherence in this population can consider this approach.Keywords
This publication has 45 references indexed in Scilit:
- Prevalence of menopausal symptoms and their influence on adherence in women with breast cancerClimacteric, 2013
- Factors associated with compliance to adjuvant hormone therapy in Black and White women with breast cancerSpringerPlus, 2013
- The Patient's Anastrozole Compliance to Therapy (PACT) Program: a randomized, in-practice study on the impact of a standardized information program on persistence and compliance to adjuvant endocrine therapy in postmenopausal women with early breast cancerAnnals of Oncology, 2013
- A prospective, multicenter, controlled, observational study to evaluate the efficacy of a patient support program in improving patients’ persistence to adjuvant aromatase inhibitor medication for postmenopausal, early stage breast cancerBreast Cancer Research and Treatment, 2012
- Predictors of Aromatase Inhibitor Discontinuation as a Result of Treatment-Emergent Symptoms in Early-Stage Breast CancerJournal of Clinical Oncology, 2012
- The Cochrane Collaboration's tool for assessing risk of bias in randomised trialsBMJ, 2011
- Association Between Prescription Co-Payment Amount and Compliance With Adjuvant Hormonal Therapy in Women With Early-Stage Breast CancerJournal of Clinical Oncology, 2011
- Concordance of Adherence Measurement Using Self-Reported Adherence Questionnaires and Medication Monitoring DevicesPharmacoEconomics, 2010
- Adherence to Initial Adjuvant Anastrozole Therapy Among Women With Early-Stage Breast CancerJournal of Clinical Oncology, 2008
- Quantifying heterogeneity in a meta‐analysisStatistics in Medicine, 2002